John Anaya
Internal Medicine · Mobile, ALNPI 1225533557
Payments from drug & device makers
Across 73 payments — averaging $22.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$936
- GSK$122
- AstraZeneca$75
- Mallinckrodt Hospital Products Inc.$59
- Pfizer$57
- Calliditas Therapeutics US Inc.$48
- plus $329 from 15 others
What the payments were for
- Food & beverage$1,626100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 41 | $936 |
| GSK | 1 | $122 |
| AstraZeneca(2 entities) | 4 | $75 |
| Mallinckrodt Hospital Products Inc. | 3 | $59 |
| Pfizer | 4 | $57 |
| Calliditas Therapeutics US Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $42 |
| Bayer | 2 | $34 |
| Amgen | 1 | $31 |
| United Therapeutics Corporation | 2 | $28 |
| Veloxis Pharmaceuticals, Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $21 |
| Sanofi | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Sandoz | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Novo Nordisk | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,626 in reported general payments places this provider in the 65th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $6,392 |
| Calcitriol | 12 | $241 |
| Lisinopril | 22 | $111 |
| Furosemide | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Mobile
- Harry StuddardMobile$12.9M
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Bobby WrightsMobile$89K
- Rahel AzizMobile$67K
- Jamie CaudillMobile$52K
- Thomas GarthMobile$48K
- Lin LiMobile$45K
- Edward CarlosMobile$26K
- Donald SandersMobile$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.